CSIMarket Company Name, Ticker, Customers, else..
 
Iterum Therapeutics Plc  (NASDAQ: ITRM)
 

Iterum Therapeutics Plc's Suppliers Performance

ITRM's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ITRM Costs vs Sales of Suppliers Growth

• More on ITRM Suppliers






Iterum Therapeutics Plc's Comment on Supply Chain


The company employs a dual sourcing strategy for the sulopenem etzadroxil API, with two registered suppliers and one validated supplier, each capable of producing commercial-scale quantities under cGMP conditions. A third-party manufacturer produces the ORLYNVAH™ bilayer tablets. The company may consider additional sources if it pursues commercialization of ORLYNVAH™ in the United States. As of January 31, 2025, a three-person team manages relationships with these manufacturers and oversees the manufacturing process.

Iterum Therapeutics Plc's Comment on Supply Chain


The company employs a dual sourcing strategy for the sulopenem etzadroxil API, with two registered suppliers and one validated supplier, each capable of producing commercial-scale quantities under cGMP conditions. A third-party manufacturer produces the ORLYNVAH™ bilayer tablets. The company may consider additional sources if it pursues commercialization of ORLYNVAH™ in the United States. As of January 31, 2025, a three-person team manages relationships with these manufacturers and oversees the manufacturing process.







ITRM's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Iterum Therapeutics Plc 3.44 14.32 -26.96 18
SUBTOTAL 0.00 0.00 0.00 -


Sources: Iterum Therapeutics Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Iterum Therapeutics Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.